Performance of ARWR Arrowhead | -18.3% in 12m
Compare ARWR with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Arrowhead with its related Sector/Index XBI
![Compare Arrowhead with its related Sector/Index XBI](https://www.valueray.com/images/chart/ARWR.NASDAQ_perf.png)
Performance Duell ARWR vs XBI
TimeFrame | ARWR | XBI |
---|---|---|
1 Day | -2.59% | 0.55% |
1 Week | -0.39% | 4.13% |
1 Month | 7.35% | 10.14% |
3 Months | 27.4% | 21.77% |
6 Months | -13.9% | 15.22% |
12 Months | -18.3% | 20.63% |
YTD | -9.09% | 12.67% |
Rel. Perf. 1m | -0.07 | |
Rel. Perf. 3m | -0.66 | |
Rel. Perf. 6m | -2.71 | |
Rel. Perf. 12m | -2.71 |
Is Arrowhead a good stock to buy?
No, based on ValueRay Fundamental Analyses, Arrowhead (NASDAQ:ARWR) is currently (July 2024)
a stock to sell. It has a ValueRay Fundamental Rating of -80.11 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ARWR as of July 2024 is 27.51. This means that ARWR is currently overvalued and has a potential downside of -2.41% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ARWR as of July 2024 is 27.51. This means that ARWR is currently overvalued and has a potential downside of -2.41% (Sold with Premium).
Is ARWR a buy, sell or hold?
- Strong Buy: 7
- Buy: 3
- Hold: 5
- Sell: 0
- Strong Sell: 0
Values above 0%: ARWR is performing better - Values below 0%: ARWR is underperforming
Compare ARWR with Broad Market Indices
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 0.44% | 7.55% | -26.33% | -38.93% |
US NASDAQ 100 | QQQ | 2.19% | 10.97% | -23.48% | -39.84% |
US Dow Jones Industrial 30 | DIA | -1.14% | 3.54% | -21.38% | -34.61% |
German DAX 40 | DBXD | -1.78% | 5.91% | -22.02% | -33.20% |
UK FTSE 100 | ISFU | -1.58% | 4.74% | -25.47% | -33.51% |
Shanghai Shenzhen CSI 300 | CSI 300 | 2.61% | 7.65% | -16.04% | -2.75% |
Hongkong Hang Seng | HSI | 1.03% | 8.13% | -9.92% | 1.67% |
Japan Nikkei 225 | EXX7 | 1.12% | 8.50% | -15.46% | -29.25% |
India NIFTY 50 | INDA | -1.53% | 4.45% | -29.43% | -45.28% |
Brasil Bovespa | EWZ | 0.54% | 5.96% | 0.21% | -5.94% |
ARWR Arrowhead vs. Sectors
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 1.27% | 9.98% | -22.25% | -41.27% |
Consumer Discretionary | XLY | 2.38% | 7.74% | -20.75% | -24.28% |
Consumer Staples | XLP | -0.90% | 5.74% | -23.61% | -25.02% |
Energy | XLE | -0.20% | 5.58% | -25.11% | -27.25% |
Financial | XLF | -1.70% | 1.52% | -27.10% | -43.33% |
Health Care | XLV | -1.80% | 4.71% | -22.41% | -31.94% |
Industrial | XLI | -1.54% | 3.56% | -25.99% | -34.57% |
Materials | XLB | -1.74% | 4.26% | -25.54% | -27.05% |
Real Estate | XLRE | -0.93% | -0.52% | -21.54% | -28.83% |
Technology | XLK | 1.69% | 11.75% | -21.49% | -40.55% |
Utilities | XLU | -1.87% | 3.89% | -32.10% | -28.09% |
Aerospace & Defense | XAR | -4.03% | 1.66% | -29.00% | -38.07% |
Biotech | XBI | -4.52% | -2.79% | -29.14% | -38.97% |
Homebuilder | XHB | -4.68% | -8.65% | -37.73% | -57.68% |
Retail | XRT | -2.48% | 4.72% | -25.03% | -33.83% |
Does Arrowhead outperform its market, is ARWR a Sector Leader?
No, over the last 12 months Arrowhead (ARWR) made -18.34%, while its related Sector, the SPDR S&P Biotech (XBI) made 20.63%.
Over the last 3 months ARWR made 27.44%, while XBI made 21.77%.
No, over the last 12 months Arrowhead (ARWR) made -18.34%, while its related Sector, the SPDR S&P Biotech (XBI) made 20.63%.
Over the last 3 months ARWR made 27.44%, while XBI made 21.77%.
Period | ARWR | XBI | S&P 500 |
---|---|---|---|
1 Month | 7.35% | 10.14% | -0.20% |
3 Months | 27.44% | 21.77% | 7.46% |
12 Months | -18.34% | 20.63% | 20.59% |